R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
First company in the world to launch Ryaltris-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
The drug is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer and ovarian, cervical and renal cancer
Subscribe To Our Newsletter & Stay Updated
